# Project health decision: data platform migration

Sponsor · Evidence as of the supplied account; year and report date unspecified

## Recommendation

**Health: Green, provisional · Confidence: Medium.** Continue the team's current response; do not commission a recovery consultant or add two contractors on this evidence. The original end-of-September target slipped two weeks, but business stakeholders approved the new mid-October commitment. The reported cause has a completed, tested workaround, six prior milestones were met, and QA is embedded. Verify that the workaround and remaining plan support the approved date through ordinary delivery governance.

## Findings that change the decision

| Evidence and source | Implication for the commitment | Confidence / competing explanation |
|---|---|---|
| User reports a two-week slip and business approval of mid-October. | The original commitment slipped; the current assessment concerns the approved date. | Clear reported rebaseline, though the exact date and approval record were not provided. |
| Team attributes the delay to export API rate limiting and reports a completed, tested batching workaround. | The identified dependency constraint appears managed, supporting continuation. | Attributed team account, not independently inspected test evidence. Tests might not yet cover production volumes or operational limits. |
| Six previous milestones met; remaining work reportedly unchanged; embedded QA. | Delivery history and quality ownership support confidence in the existing team and response. | Positive contextual evidence, not a guarantee that remaining migration and cutover work will succeed. |

The mechanism reported is specific: export limits delayed migration work, and batching mitigates those limits. A plausible competing explanation is that the workaround passes functional tests but cannot achieve required throughput at production scale. That is a focused verification question, not a reason to assume a broader delivery failure. The remaining acceptance, cutover, rollback and operational plan has not been supplied, so Green remains provisional.

The CEO's concern is understandable as scrutiny of the original slip, but intervention should resolve a live constraint. No continuing capacity shortage, unowned dependency or separable work queue has been identified. Added staff would require access, onboarding and review time from the team; there is no evidence their contribution would arrive before the revised finish date or remove the API constraint.

## This week

| Action or leadership decision | Proposed owner / needed by | Evidence or outcome produced |
|---|---|---|
| Confirm the exact approved date and remaining acceptance/cutover milestones in the existing plan. | Project lead and business sponsor / next status review | One current commitment and explicit remaining readiness checks. |
| Show workaround test results covering expected data volume, provider limits and completion time. | Migration lead and embedded QA / this week | Evidence the reported constraint is removed under representative conditions. |
| Continue normal milestone and readiness monitoring, escalating only a material variance. | Project lead / next weekly review | Updated forecast and evidence, without a separate recovery reporting burden. |

Tell the CEO: “We missed the original date by two weeks. Stakeholders approved mid-October, and the team reports the specific blocker resolved and tested. Current evidence supports that commitment. We are checking production-scale performance and remaining cutover readiness; additional staffing has no demonstrated bottleneck to solve.”

## What could change the recommendation

A failed throughput check, new unowned dependency or remaining release work that cannot fit the approved window would change the assessment. First seek the test evidence and remaining plan. Consider targeted external expertise only if those expose a specialist constraint that the team cannot resolve in time. There is no current basis for broad recovery intervention.
